Payal Sahni
Executive Vice President, Pfizer.
Companies
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 25, 2026Shares withheld for tax 54,066 shares at $26.92 of Pfizer2
- Feb 25, 2026Shares withheld for tax 1,083 shares at $27.09 of Pfizer2
- Feb 25, 2026Exercised options 56,888 shares at $33.82 of Pfizer2
- Feb 27, 2025Shares withheld for tax 17,846 shares at $26.06 of Pfizer3
- Feb 27, 2025Shares withheld for tax 468 shares at $26.10 of Pfizer3
- Feb 27, 2025Exercised options 19,054 shares at $31.31 of Pfizer3
- Feb 22, 2025Shares withheld for tax 11,343 shares at $26.08 of Pfizer4
- Feb 22, 2025Shares withheld for tax 568 shares at $26.30 of Pfizer4
- Feb 22, 2025Exercised options 12,714 shares at $30.17 of Pfizer4
- Feb 23, 2024Shares withheld for tax 9,314 shares at $27.37 of Pfizer5
- Feb 23, 2024Shares withheld for tax 905 shares at $27.76 of Pfizer5
- Feb 23, 2024Exercised options 11,527 shares at $27.34 of Pfizer5
- Feb 27, 2023Shares withheld for tax 1,297 shares at $40.78 of Pfizer6
- Feb 25, 2023Shares withheld for tax 3,967 shares at $43.44 of Pfizer6
- Feb 25, 2023Shares withheld for tax 1,786 shares at $41.75 of Pfizer6
- Feb 25, 2023Exercised options 8,921 shares at $22.89 of Pfizer6
- Feb 22, 2023Shares withheld for tax 9,259 shares at $43.70 of Pfizer7
- Feb 22, 2023Shares withheld for tax 2,206 shares at $42.38 of Pfizer7
- Feb 22, 2023Exercised options 15,209 shares at $30.17 of Pfizer7
- May 13, 2022Sold 1,408 shares at $49.84 of Pfizer8
- Feb 28, 2022Shares withheld for tax 1,049 shares at $46.94 of Pfizer9
- Feb 23, 2022Shares withheld for tax 6,872 shares at $51.28 of Pfizer10
- Feb 23, 2022Shares withheld for tax 2,717 shares at $46.87 of Pfizer10
- Feb 23, 2022Exercised options 13,884 shares at $27.34 of Pfizer10
- Feb 25, 2021Shares withheld for tax 6,460 shares at $34.76 of Pfizer11
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| May 13, 2022 | PFE | Sale | $70.2K | −41.0% | +133.1% | +28.4% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPfizer, Executive Vice President
- 2
- 3SEC EDGARForm 4 filed Mar 3, 2025
- 4SEC EDGARForm 4 filed Feb 25, 2025
- 5SEC EDGARForm 4 filed Feb 27, 2024
- 6SEC EDGARForm 4 filed Feb 28, 2023
- 7SEC EDGARForm 4 filed Feb 24, 2023
- 8SEC EDGARForm 4 filed May 16, 2022
- 9SEC EDGARForm 4 filed Mar 1, 2022
- 10SEC EDGARForm 4 filed Feb 25, 2022
- 11SEC EDGARForm 4 filed Mar 1, 2021